Geneoscopy

Geneoscopy company information, Employees & Contact Information

Explore related pages

Related company profiles:

Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.

Company Details

Employees
64
Founded
-
Address
2220 Welsch Industrial Ct, St. Louis,mo 63146,united States
Phone
314-887-7777
Email
ge****@****ail.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
St. Louis, MO
Looking for a particular Geneoscopy employee's phone or email?

Geneoscopy Questions

News

Geneoscopy’s Scrape-Free Collection Method for Colorectal Cancer Screening Validated by New Data and Peer-Reviewed Publication - Business Wire

Geneoscopy’s Scrape-Free Collection Method for Colorectal Cancer Screening Validated by New Data and Peer-Reviewed Publication Business Wire

Geneoscopy’s New FDA-Approved Stool Collection Method Simplifies At-Home Colorectal Cancer Screening - Yahoo Finance

Geneoscopy’s New FDA-Approved Stool Collection Method Simplifies At-Home Colorectal Cancer Screening Yahoo Finance

Legal Win for Geneoscopy as Exact Sciences Withdraws Preliminary Injunction Against ColoSense - Business Wire

Legal Win for Geneoscopy as Exact Sciences Withdraws Preliminary Injunction Against ColoSense Business Wire

Geneoscopy’s RNA-Based ColoSense Test Included in Latest National Comprehensive Cancer Network (NCCN) Guidelines - Yahoo Finance

Geneoscopy’s RNA-Based ColoSense Test Included in Latest National Comprehensive Cancer Network (NCCN) Guidelines Yahoo Finance

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests - Business Wire

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests Business Wire

NCCN Adds 2 Tests to CRC Screening Guidelines - OncLive

NCCN Adds 2 Tests to CRC Screening Guidelines OncLive

Geneoscopy Prepares Launch of FDA-approved At-home RNA Colorectal Cancer Screening Test - Medical Device and Diagnostic industry

Geneoscopy Prepares Launch of FDA-approved At-home RNA Colorectal Cancer Screening Test Medical Device and Diagnostic industry

Fire Awards 2025: Geneoscopy secures $105M to expand gastrointestinal health diagnostics - The Business Journals

Fire Awards 2025: Geneoscopy secures $105M to expand gastrointestinal health diagnostics The Business Journals

Geneoscopy's Noninvasive Colorectal Cancer Screening Test Demonstrates High Sensitivity and Specificity in Large Pivotal Clinical Trial - PR Newswire

Geneoscopy's Noninvasive Colorectal Cancer Screening Test Demonstrates High Sensitivity and Specificity in Large Pivotal Clinical Trial PR Newswire

Geneoscopy wins FDA approval for Labcorp-partnered colon cancer test - MedTech Dive

Geneoscopy wins FDA approval for Labcorp-partnered colon cancer test MedTech Dive

FDA Approves ColoSense, a Noninvasive mt-sRNA Test, for Adults 45 or Older - HCPLive

FDA Approves ColoSense, a Noninvasive mt-sRNA Test, for Adults 45 or Older HCPLive

Geneoscopy Wins Patent Trial and Appeal Board Decision, Invalidating All 20 Claims of Exact Sciences’ ’781 Patent - Business Wire

Geneoscopy Wins Patent Trial and Appeal Board Decision, Invalidating All 20 Claims of Exact Sciences’ ’781 Patent Business Wire

PTAB hands Exact a loss in Geneoscopy patent dispute - BioWorld MedTech

PTAB hands Exact a loss in Geneoscopy patent dispute BioWorld MedTech

Exact’s Cancer-Screening Patent Invalidated in Geneoscopy Win - Bloomberg Law News

Exact’s Cancer-Screening Patent Invalidated in Geneoscopy Win Bloomberg Law News

Geneoscopy, with home test for colorectal cancer, names first CFO - The Business Journals

Geneoscopy, with home test for colorectal cancer, names first CFO The Business Journals

FDA Approves Noninvasive Stool RNA Screening Test for CRC - OncLive

FDA Approves Noninvasive Stool RNA Screening Test for CRC OncLive

Geneoscopy Sibling Co-founders Named Finalists for EY Entrepreneur Of The Year 2025 Heartland Award - Business Wire

Geneoscopy Sibling Co-founders Named Finalists for EY Entrepreneur Of The Year 2025 Heartland Award Business Wire

Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention - PR Newswire

Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention PR Newswire

FDA Approves ColoSense™ – Geneoscopy's Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test - FinancialContent

FDA Approves ColoSense™ – Geneoscopy's Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test FinancialContent

Geneoscopy nabs $105M to advance RNA-based gut tests for early colorectal cancer screening - Fierce Biotech

Geneoscopy nabs $105M to advance RNA-based gut tests for early colorectal cancer screening Fierce Biotech

Top Geneoscopy Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant